Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05574478 · ClinicalTrials.gov registry record
Metastatic Breast Cancer-Specific Prognostic Tool
A clinical trial, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- 19
- Enrollment target
NCT05574478 is a clinical trial that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 19 participants.
The verdict
NCT05574478 has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
In this qualitative study, Investigators will conduct semi-structured interviews with clinicians that are involved in the care of patients with breast cancer to evaluate the acceptability, appropriateness, and feasibility/usability of a metastatic breast cancer-specific prognostic tool. These interviews will be conducted by the UNC CHAI Core and will continue until thematic saturation (estimated 20-30 participants). The investigators will code the qualitative data using emerging themes, guided by a well-established implementation science theory, the Consolidated Framework for Implementation Research (CFIR). The information gained from these studies will inform an implementation approach to increase the usability and acceptability of a novel prognostic tool to assist oncologists in the prognosis of patients with metastatic breast cancer.
Interventions
- BEHAVIORAL Patients and Caregivers Qualitative Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2022-09-20 |
| Est. Completion | 2024-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05574478
The ClinicalTrials.gov registry entry for NCT05574478 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Patients and Caregivers Qualitative Interview is the first listed.
NCT05574478 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05574478 about?
NCT05574478 is a clinical study titled "Metastatic Breast Cancer-Specific Prognostic Tool". In this qualitative study, Investigators will conduct semi-structured interviews with clinicians that are involved in the care of patients with breast cancer to evaluate the acceptability, appropriateness, and feasibility/usability of a metastatic breast cancer-specific prognostic tool. These interv...
What is the current status of trial NCT05574478?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2022-09-20. Estimated completion is 2024-02-28.
What interventions are being tested in trial NCT05574478?
The interventions under investigation include: Patients and Caregivers Qualitative Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT05574478?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.